TrialAnnals of internal medicine2019

Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse.

Sean M Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.